Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs) (THRIVE)
Long-Term Registry of Patients With Urea Cycle Disorders (UCDs)
Sponsor: Amgen
Terminated
the study was terminated due to the primary end point being met.
Other terminated trials from Amgen
Other Urea Cycle Disorder trials with similar outcome
Listed as NCT01948427, this observational or N/A phase trial focuses on Urea Cycle Disorder and remains terminated or withdrawn. Sponsored by Amgen, it has been updated 12 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Aug 2024 — Sep 2024 [monthly]
Terminated
-
Jul 2024 — Aug 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Mar 2021 — Dec 2021 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
▶ Show 7 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting
-
Jun 2019 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2019 — Jun 2019 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jan 2018 [monthly]
Recruiting NA
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amgen
For direct contact, visit the study record on ClinicalTrials.gov .